TASK DEFINITION: Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
PROBLEM: Paragraph: Saturday marks the Drug Enforcement Administration’s nationwide “Drug Take Back Day.” Only pills or patches can be accepted, not liquids or needles. A list of collection sites is available on the DEA’s website. The Illinois Environmental Protection Agency’s website also provides a list of medication collection sites around the state. People turned in nearly 469 tons of prescription drugs nationwide last year. The Illinois Department of Human Services says turning in unused or expired prescription drugs can prevent abuse or theft of the drugs. Claim: Collection sites available for expired, leftover medications.

SOLUTION: Illinois and federal officials are encouraging people to bring expired and unused prescription drugs to collection sites.

PROBLEM: Paragraph: "The sight of the moon’s shadow passing directly in front of the sun, blotting out all but the halo-like solar corona, may draw the largest live audience for a celestial event in human history. When those watching via broadcast and online media are factored into the mix, the spectacle will likely smash records. “It will certainly be the most observed total eclipse in history,” astronomer Rick Fienberg of the American Astronomical Society (AAS) said last week. The eclipse begins its cross-country trajectory over the Pacific Coast of Oregon in late morning. It will reach South Carolina’s Atlantic shore some 90 minutes later. The total eclipse of the sun is considered one of the most spell-binding phenomena in nature but it rarely occurs over a wide swath of land, let alone one of the world’s most heavily populated countries at the height of summer. In terms of audience potential, it is hard to top the United States, with its mobile and affluent population, even though the direct path is mostly over rural areas, towns and small cities. The largest is Nashville, Tennessee, a city of 660,000 residents. Even so the advent of social media and inexpensive high-tech optics have boosted public awareness, assuring what many U.S. experts predict will be unprecedented viewership for the so-called “Great American Eclipse.”   Some might take issue with that prediction, citing a solar eclipse visible over parts of India, Nepal, Bangladesh and central China in July 2009. National Geographic estimated 30 million people in Shanghai and Hangzhou alone were in its path that day. On Monday, the deepest part of the shadow, or umbra, cast by the moon will fall over a 70-mile-wide (113-km-wide), 2,500-mile-long (4,000-km-long) ""path of totality"" traversing 14 states. The 12 million people who live there can view the eclipse at its fullest merely by walking outside and looking up, weather permitting. (tmsnrt.rs/2fNQHFb)  LIVESTREAMING AND PRICE-GOUGING  Some 200 million Americans reside within a day’s drive of the totality zone, and as many as 7 million, experts say, are expected to converge on towns and campgrounds along the narrow corridor for the event. Many are attending multiday festivals featuring music, yoga and astronomy lectures. Millions more could potentially watch in real time as the eclipse is captured by video cameras mounted on 50 high-altitude balloons and streamed online in a joint project between NASA and Montana State University. A partial eclipse will appear throughout North America. Adding further to the excitement is the wide availability of affordable solar-safe sunglasses produced by the millions and selling so fast that suppliers were running out of stock. The owner of one leading manufacturer reported price gouging by second-hand dealers who were buying up large supplies and reselling them over the internet at a huge mark-up. Not all the hoopla will unfold on dry land. Welsh pop singer Bonnie Tyler is slated to perform her 1983s hit single “Total Eclipse of the Heart” aboard a cruise liner as the vessel sails into the path of totality from Florida on Monday. Back on the ground, forest rangers, police and city managers in the total eclipse zone are bracing for a crush of travelers they fear will cause epic traffic jams and heighten wildfire hazards. “Imagine 20 Woodstock festivals occurring simultaneously across the nation,” Michael Zeiler, an AAS advisory panel member wrote on his website, GreatAmericanEclipse.com, referring to the famously chaotic 1969 outdoor rock extravaganza in upstate New York. Hundreds of residents in a prime-viewing area in Oregon had to evacuate on Saturday under threat from a wildfire raging in the Deschutes National Forest, according to InciWeb fire-tracking website. The so-called Milli Fire, which has scorched more than 7,8OO acres (3,162 hectare), is one of seven burning in Oregon, Montana and Idaho, three of the states crossed by the totality path. Zeiler, an avowed “eclipse chaser” who made the 650-mile (1,046-km) drive from his New Mexico home to Wyoming for a choice view, said South Carolina is likely to see the greatest influx as the destination state closest to the entire U.S. Eastern seaboard. Monday’s event will be the first total solar eclipse spanning the entire continental United States since 1918 and the first visible anywhere in the Lower 48 states in 38 years. The next one over North America is due in just seven years, in April 2024." Claim: Millions of Americans to gaze upon Monday's once-in-a-lifetime eclipse.

SOLUTION: Twilight will fall at midday on Monday, stars will glimmer and birds will roost in an eerie stillness as millions of Americans and visitors witness the first total solar eclipse to traverse the United States from coast to coast in 99 years.

PROBLEM: Paragraph: The review, posted on the FDA’s website on Monday, comes two days ahead of a meeting of outside medical experts who are expected to recommend whether it should be approved. The FDA usually follows the advice of its advisory panels. The drug, which would be sold under the brand name Zontivity, is designed to prevent heart-related deaths, cardiac arrests and strokes in patients who have had a recent heart attack. It would not be recommended for patients who have previously had a stroke because of an increased risk of bleeding in the brain. Results from a trial known as TRA 2P “are sufficient to establish the effectiveness of vorapaxar for its proposed indication,” the review found. The main safety concern with the drug is bleeding, the review found, though it noted that the rate of fatal bleeding was low in the population for whom the drug is proposed. The FDA did not recommend that the company establish a risk management program, nor did it recommend that the company conduct additional trials following approval. Vorapaxar works by preventing blood cells, known as platelets, from clumping together and forming clots in the arteries, which can lead to heart attacks. Other anti-platelets include aspirin and Plavix, which is made by Bristol-Myers Squibb Co. Merck’s drug works in a different way, by inhibiting a receptor known as PAR-1. Each year about 525,000 Americans have heart attacks and about 190,000 have a second heart-related event, according to Merck. Standard therapy to prevent a second episode often includes treatment with aspirin and Plavix. Voraxapar would be given in addition to standard treatment. During clinical trials, safety monitors found that patients who had previously had a stroke were at higher risk of bleeding in the brain and were instructed to stop taking the drug. Merck then focused its analysis on patients who had had a heart attack but no stroke. Merck’s shares rose 2.7 percent to $51.21 in early trading, helped also by news it had initiated its application to market a drug for patients with advanced melanoma. The company also said it is pursuing strategic options for its animal health and consumer businesses and expects to complete any action this year. Claim: Merck's anti-blood clot drug should be approved: FDA review.

SOLUTION:
Merck & Co Inc’s experimental blood clot-preventing drug vorapaxar should be approved, based on “robustly positive” clinical trial results, according to a preliminary review of the data by the U.S. Food and Drug Administration.